Divalproex Delayed Release Tablets and Lixisenatide Subcutaneous
Determining the interaction of Divalproex Delayed Release Tablets and Lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Delayed Release Tablets-Lixtraxen Injection
- Divalproex Delayed Release Tablets-LMD
- Divalproex Delayed Release Tablets-LMD Injection
- Divalproex Delayed Release Tablets-LMX 4 Topical application
- Divalproex Delayed Release Tablets-LMX 5
- Divalproex Delayed Release Tablets-LMX 5 Topical application
- Lixisenatide Subcutaneous-Divalproex Extended Release
- Lixisenatide Subcutaneous-Divalproex Long-Acting Tablets
- Lixisenatide Subcutaneous-Divalproex sodium
- Lixisenatide Subcutaneous-Divalproex Sprinkle
- Lixisenatide Subcutaneous-Divalproex Sprinkle Capsules
- Lixisenatide Subcutaneous-Divigel